Albumin administration prevents neurological damage and death in a mouse model of severe neonatal hyperbilirubinemia

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Vodret, Simone ^a   Bortolussi, Giulia ^a   Schreuder, Andrea B ^b   Jašprová, Jana ^c   Vitek, Libor ^c   Verkade, Henkjan J ^b   Muro, Andrés F ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; SERUM ALBUMIN;

ANIMAL; BLOOD; CEREBELLUM; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; HUMAN; MOUSE; NEONATAL HYPERBILIRUBINEMIA; NERVOUS SYSTEM DISEASES; NEWBORN JAUNDICE; PHOTOTHERAPY; PROCEDURES;

ANIMALS; BILIRUBIN; CEREBELLUM; DISEASE MODELS, ANIMAL; HUMANS; HYPERBILIRUBINEMIA, NEONATAL; JAUNDICE, NEONATAL; MICE; NERVOUS SYSTEM DISEASES; PHOTOTHERAPY; SERUM ALBUMIN;

EID: 84946887783     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep16203     Document Type: Article

References (55)

1. Johnson, L. H., Bhutani, V. K. & Brown, A. K. System-based approach to management of neonatal jaundice and prevention of kernicterus. The Journal of pediatrics 140, 396-403, doi: 10.1067/mpd.2002.123098 (2002).
2. American-Academy-of-Pediatrics. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 114, 297-316 (2004).
3. Watchko, J. F. & Tiribelli, C. Bilirubin-induced neurologic damage-mechanisms and management approaches. The New England journal of medicine 369, 2021-2030, doi: 10.1056/NEJMra1308124 (2013).
4. Burgos, A. E., Flaherman, V. J. & Newman, T. B. Screening and follow-up for neonatal hyperbilirubinemia: a review. Clinical pediatrics 51, 7-16, doi: 10.1177/0009922811398964 (2012).
5. Kaplan, M., Bromiker, R. & Hammerman, C. Severe neonatal hyperbilirubinemia and kernicterus: are these still problems in the third millennium? Neonatology 100, 354-362, doi: 10.1159/000330055 (2011).
6. Morioka, I. et al. Current incidence of clinical kernicterus in preterm infants in Japan. Pediatrics international: official journal of the Japan Pediatric Society 57, 494-497, doi: 10.1111/ped.12651 (2015).
7. Gamaleldin, R. et al. Risk factors for neurotoxicity in newborns with severe neonatal hyperbilirubinemia. Pediatrics 128, e925-931, doi: 10.1542/peds.2011-0206 (2011).
8. Iskander, I. et al. Serum bilirubin and bilirubin/albumin ratio as predictors of bilirubin encephalopathy. Pediatrics 134, e1330-1339, doi: 10.1542/peds.2013-1764 (2014).
9. Owa, J. A. & Ogunlesi, T. A. Why we are still doing so many exchange blood transfusion for neonatal jaundice in Nigeria. World journal of pediatrics: WJP 5, 51-55, doi: 10.1007/s12519-009-0009-2 (2009).
10. Slusher, T. M., Zipursky, A. & Bhutani, V. K. A global need for affordable neonatal jaundice technologies. Seminars in perinatology 35, 185-191, doi: 10.1053/j.semperi.2011.02.014 (2011).
11. English, M. et al. Outcome of delivery and cause-specific mortality and severe morbidity in early infancy: a Kenyan District Hospital birth cohort. The American journal of tropical medicine and hygiene 69, 228-232 (2003).
12. Ezeaka, V. C., Ekure, E. N., Iroha, E. O. & Egri-Okwaji, M. T. Outcome of low birth weight neonates in a tertiary health care centre in Lagos, Nigeria. African journal of medicine and medical sciences 33, 299-303 (2004).
13. Owa, J. A. & Osinaike, A. I. Neonatal morbidity and mortality in Nigeria. Indian journal of pediatrics 65, 441-449 (1998).
14. Bhutani, V. K. & Wong, R. J. Bilirubin neurotoxicity in preterm infants: risk and prevention. Journal of clinical neonatology 2, 61-69, doi: 10.4103/2249-4847.116402 (2013).
15. Ibekwe, R. C., Ibekwe, M. U. & Muoneke, V. U. Outcome of exchange blood transfusions done for neonatal jaundice in abakaliki, South eastern Nigeria. Journal of clinical neonatology 1, 34-37, doi: 10.4103/2249-4847.92239 (2012).
16. Hosseinpour Sakha, S. & Gharehbaghi, M. M. Exchange transfusion in severe hyperbilirubinemia: an experience in northwest Iran. The Turkish journal of pediatrics 52, 367-371 (2010).
17. Jackson, J. C. Adverse events associated with exchange transfusion in healthy and ill newborns. Pediatrics 99, E7 (1997).
18. Keenan, W. J., Novak, K. K., Sutherland, J. M., Bryla, D. A. & Fetterly, K. L. Morbidity and mortality associated with exchange transfusion. Pediatrics 75, 417-421 (1985).
19. Sa, C. A. M., Santos, M. C. P., de Carvalho, M. & Moreira, M. E. L. Adverse events related to exchange transfusion in newborn infants with hemolytic disease: ten years of experience. Rev Paul Pediatr 27, 168-172 (2009).
20. Davutoglu, M., Garipardic, M., Guler, E., Karabiber, H. & Erhan, D. The etiology of severe neonatal hyperbilirubinemia and complications of exchange transfusion. The Turkish journal of pediatrics 52, 163-166 (2010).
21. Ostrow, J. D., Mukerjee, P. & Tiribelli, C. Structure and binding of unconjugated bilirubin: relevance for physiological and pathophysiological function. J Lipid Res 35, 1715-1737 (1994).
22. Ostrow, J. D. & Schmid, R. The Protein-Binding of C14-Bilirubin in Human and Murine Serum. The Journal of clinical investigation 42, 1286-1299, doi: 10.1172/JCI104813 (1963).
23. Brodersen, R. Bilirubin. Solubility and interaction with albumin and phospholipid. The Journal of biological chemistry 254, 2364-2369 (1979).
24. Ostrow, J. D., Pascolo, L., Brites, D. & Tiribelli, C. Molecular basis of bilirubin-induced neurotoxicity. Trends in molecular medicine 10, 65-70, doi: 10.1016/j.molmed.2003.12.003 (2004).
25. Ahlfors, C. E., Amin, S. B. & Parker, A. E. Unbound bilirubin predicts abnormal automated auditory brainstem response in a diverse newborn population. Journal of perinatology: official journal of the California Perinatal Association 29, 305-309, doi: 10.1038/jp.2008.199 (2009).
26. Comley, A. & Wood, B. Albumin administration in exchange transfusion for hyperbilirubinaemia. Archives of disease in childhood 43, 151-154 (1968).
27. Ebbesen, F. & Brodersen, R. Comparison between two preparations of human serum albumin in treatment of neonatal hyperbilirubinaemia. Acta paediatrica Scandinavica 71, 85-90 (1982).
28. Hosono, S. et al. Follow-up study of auditory brainstem responses in infants with high unbound bilirubin levels treated with albumin infusion therapy. Pediatrics international: official journal of the Japan Pediatric Society 44, 488-492 (2002).
29. Odell, G. B., Cohen, S. N. & Gordes, E. H. Administration of albumin in the management of hyperbilirubinemia by exchange transfusions. Pediatrics 30, 613-621 (1962).
30. Shahian, M. & Moslehi, M. A. Effect of albumin administration prior to exchange transfusion in term neonates with hyperbilirubinemia-a randomized controlled trial. Indian pediatrics 47, 241-244 (2010).
31. Tsao, Y. C. & Yu, V. Y. Albumin in management of neonatal hyperbilirubinaemia. Archives of disease in childhood 47, 250-256 (1972).
32. Wood, B., Comley, A. & Sherwell, J. Effect of additional albumin administration during exchange transfusion on plasma albuminbinding capacity. Archives of disease in childhood 45, 59-62 (1970).
33. Cuperus, F. J. et al. Beyond plasma bilirubin: the effects of phototherapy and albumin on brain bilirubin levels in Gunn rats. Journal of hepatology 58, 134-140, doi: 10.1016/j.jhep.2012.08.011 (2013).
34. Schreuder, A. B. et al. Albumin administration protects against bilirubin-induced auditory brainstem dysfunction in Gunn rat pups. Liver international: official journal of the International Association for the Study of the Liver 33, 1557-1565, doi: 10.1111/liv.12219 (2013).
35. Rice, A. C. & Shapiro, S. M. A new animal model of hemolytic hyperbilirubinemia-induced bilirubin encephalopathy (kernicterus). Pediatric research 64, 265-269 (2008).
36. Bortolussi, G. et al. Age-dependent pattern of cerebellar susceptibility to bilirubin neurotoxicity in ivo in mice. Disease models & mechanisms 7, 1057-1068, doi: 10.1242/dmm.016535 (2014).
37. Bortolussi, G. et al. Rescue of bilirubin-induced neonatal lethality in a mouse model of Crigler-Najjar syndrome type I by AAV9-mediated gene transfer. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 26, 1052-1063, doi: 10.1096/fj.11-195461 (2012).
38. Fanali, G. et al. Human serum albumin: from bench to bedside. Molecular aspects of medicine 33, 209-290, doi: 10.1016/j. mam.2011.12.002 (2012).
39. Bennhold, H. & Kallee, E. Comparative studies on the half-life of I 131-labeled albumins and nonradioactive human serum albumin in a case of analbuminemia. The Journal of clinical investigation 38, 863-872, doi: 10.1172/JCI103868 (1959).
40. Greissman, A., Silver, P., Nimkoff, L. & Sagy, M. Albumin bolus administration versus continuous infusion in critically ill hypoalbuminemic pediatric patients. Intensive care medicine 22, 495-499 (1996).
41. Chaudhury, C. et al. The major histocompatibility complex-related Fc receptor for IgG (FcRn) binds albumin and prolongs its lifespan. The Journal of experimental medicine 197, 315-322 (2003).
42. Andersen, J. T. et al. Extending serum half-life of albumin by engineering neonatal Fc receptor (FcRn) binding. The Journal of biological chemistry 289, 13492-13502, doi: 10.1074/jbc.M114.549832 (2014).
43. Andersen, J. T., Daba, M. B., Berntzen, G., Michaelsen, T. E. & Sandlie, I. Cross-species binding analyses of mouse and human neonatal Fc receptor show dramatic differences in immunoglobulin G and albumin binding. The Journal of biological chemistry 285, 4826-4836, doi: 10.1074/jbc.M109.081828 (2010).
44. Caldera, R. et al. [The effect of human albumin in association with intensive phototherapy in the management of neonatal jaundice]. Archives francaises de pediatrie 50, 399-402 (1993).
45. Morris, B. H. et al. Aggressive vs. conservative phototherapy for infants with extremely low birth weight. The New England journal of medicine 359, 1885-1896, doi: 10.1056/NEJMoa0803024 (2008).
46. Ahlfors, C. E. & Parker, A. E. Unbound bilirubin concentration is associated with abnormal automated auditory brainstem response for jaundiced newborns. Pediatrics 121, 976-978, doi: 10.1542/peds.2007-2297 (2008).
47. Ahlfors, C. E. Criteria for exchange transfusion in jaundiced newborns. Pediatrics 93, 488-494 (1994).
48. Hulzebos, C. V. et al. The bilirubin albumin ratio in the management of hyperbilirubinemia in preterm infants to improve neurodevelopmental outcome: a randomized controlled trial-BARTrial. PloS one 9, e99466, doi: 10.1371/journal.pone.0099466 (2014).
49. Lee, Y. K., Daito, Y., Katayama, Y., Minami, H. & Negishi, H. The significance of measurement of serum unbound bilirubin concentrations in high-risk infants. Pediatrics international: official journal of the Japan Pediatric Society 51, 795-799, doi: 10.1111/j.1442-200X.2009.02878.x (2009).
50. Nakamura, H., Yonetani, M., Uetani, Y., Funato, M. & Lee, Y. Determination of serum unbound bilirubin for prediction of kernicterus in low birthweight infants. Acta paediatrica Japonica; Overseas edition 34, 642-647 (1992).
51. Morioka, I. et al. Serum unbound bilirubin as a predictor for clinical kernicterus in extremely low birth weight infants at a late age in the neonatal intensive care unit. Brain & development, doi: 10.1016/j.braindev.2015.01.001 (2015).
52. Oh, W. et al. Influence of clinical status on the association between plasma total and unbound bilirubin and death or adverse neurodevelopmental outcomes in extremely low birth weight infants. Acta paediatrica 99, 673-678, doi: 10.1111/j.1651-2227.2010.01688.x (2010).
53. Bortolussi, G. et al. Life-Long Correction of Hyperbilirubinemia with a Neonatal Liver-Specific AAV-Mediated Gene Transfer in a Lethal Mouse Model of Crigler-Najjar Syndrome. Human gene therapy 25, 844-855, doi: 10.1089/hum.2013.233 (2014).
54. Ahlfors, C. E., Marshall, G. D., Wolcott, D. K., Olson, D. C. & Van Overmeire, B. Measurement of unbound bilirubin by the peroxidase test using Zone Fluidics. Clinica chimica acta; international journal of clinical chemistry 365, 78-85, doi: 10.1016/j. cca.2005.07.030 (2006).
55. Zelenka, J. et al. Highly sensitive method for quantitative determination of bilirubin in biological fluids and tissues. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 867, 37-42, doi: 10.1016/j.jchromb.2008.03.005 (2008).